Stephen Glover was appointed as Director at ONCOLYTICS BIOTECH INC.
“appointed Stephen Glover as the ninth director of the Board”
ONCOLYTICS BIOTECH INC — fact timeline
Source-grounded facts extracted from ONCOLYTICS BIOTECH INC's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
John McAdory was appointed as Chief Operating Officer at ONCOLYTICS BIOTECH INC.
“appointed John McAdory as Chief Operating Officer of the Company”
ONCOLYTICS BIOTECH INC: Filed Articles of Incorporation and adopted Bylaws in connection with domestication from British Columbia to Nevada.
“On the Effective Date and in connection with the Domestication, the Company filed with the Nevada Secretary of State: (i) the Articles of Domestication of Oncolytics Biotech Inc. (the “Articles of Domestication”); and (ii) the Articles of Incorporation of Oncolytics Biotech Inc. (the “Articles of Incorporation”). In addition, the Company adopted bylaws (the “Bylaws”), which became effective on the Effective Date.”
ONCOLYTICS BIOTECH INC: Adopted continuation application with new Notice of Articles and Articles of Oncolytics British Columbia, changing governing documents from Alberta to British Columbia corporate law.
“In connection with the consummation of the Continuance, the Company adopted a continuation application, which contained the Notice of Articles of Oncolytics British Columbia (the “Notice of Articles”) and the Articles of Oncolytics British Columbia (the “Articles”)”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.